Literature DB >> 22949390

Bronchoscopy and airway management in patients with mucopolysaccharidoses (MPS).

Marianne S Muhlebach1, Christopher B Shaffer, Linda Georges, Kathy Abode, Joseph Muenzer.   

Abstract

INTRODUCTION: Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders characterized by tissue deposition of glycosaminoglycans (GAG). Their musculoskeletal abnormalities and the GAG storage in the airway result in increased risk for patients undergoing anesthesia. This study evaluates a multi-disciplinary airway management approach and reports upper and lower airway findings of flexible bronchoscopy performed during these procedures.
METHODS: This is a retrospective study over 10 years evaluating approaches to and outcomes of airway management and bronchoscopic findings in this patient group.
RESULTS: Thirty-one patients underwent a total of 105 anesthetic events of which 74 involved multiple surgical services. The majority of patients were either MPS I (n = 9) or MPS II (n = 19). The median age was 8.6 years (range 1.1-24 years). Airway management by anesthesiologists alone occurred in 31 cases including natural airway (n = 7), perilaryngeal airway (n = 7), oral or nasal intubation (n = 7) or tracheostomy (n = 6) and emergent fiberoptic intubation in four cases. In 74 of the procedures, flexible bronchoscopy was performed which included fiberoptic intubation in 22 cases. Post-operative complications occurred in eight cases mostly when prolonged airway instrumentation had occurred. The most frequent findings on bronchoscopy were GAG deposits/adenoid hypertrophy in 72%, laryngomalacia in 31% and lower airway deposits and/or tracheobronchomalacia in 46% of procedures. Deposits of GAG were seen in patients as young as 4 years of age.
CONCLUSION: Our experience demonstrates that a multidisciplinary approach and combined surgeries in MPS provides for safe airway management and allows diagnostic assessments for further patient care without added risks. Significant, multi-factorial airway compromise may occur already in early childhood including upper and lower airway GAG deposits.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22949390     DOI: 10.1002/ppul.22629

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  9 in total

1.  Obstructive sleep apnea and craniofacial appearance in MPS type I-Hurler children after hematopoietic stem cell transplantation.

Authors:  Till Koehne; Sarah Müller-Stöver; Anja Köhn; Katharina Stumpfe; Susanne Lezius; Carmen Schmid; Zoltan Lukacs; Bärbel Kahl-Nieke; Nicole Muschol
Journal:  Sleep Breath       Date:  2019-07-22       Impact factor: 2.816

2.  Management of Life-Threatening Tracheal Stenosis and Tracheomalacia in Patients with Mucopolysaccharidoses.

Authors:  Christoph Kampmann; Christiane M Wiethoff; Ralf G Huth; Gundula Staatz; Eugen Mengel; Michael Beck; Stefan Gehring; Torsten Mewes; Tariq Abu-Tair
Journal:  JIMD Rep       Date:  2016-07-22

3.  Emergency bronchoscopy for foreign-body aspiration in a child with type I mucopolysaccharidosis: a challenging airway management experience.

Authors:  Pinar Kendigelen; Yusuf Tunali; Ayse Tutuncu; Gulruh Ashyralyyeva; Senol Emre; Guner Kaya
Journal:  J Anesth       Date:  2016-05-04       Impact factor: 2.078

4.  Relationship of sleep to pulmonary function in mucopolysaccharidosis II.

Authors:  William I Wooten; Joseph Muenzer; Bradley V Vaughn; Marianne S Muhlebach
Journal:  J Pediatr       Date:  2013-01-08       Impact factor: 4.406

5.  Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome.

Authors:  Abhijit Ricky Pal; Eveline J Langereis; Muhammad A Saif; Jean Mercer; Heather J Church; Karen L Tylee; Robert F Wynn; Frits A Wijburg; Simon A Jones; Iain A Bruce; Brian W Bigger
Journal:  Orphanet J Rare Dis       Date:  2015-04-10       Impact factor: 4.123

6.  Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I.

Authors:  Pamela Arn; Iain A Bruce; James E Wraith; Helen Travers; Shari Fallet
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-09-11       Impact factor: 1.547

Review 7.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 8.  The role of imaging in the skeletal involvement of mucopolysaccharidoses.

Authors:  Vincenzo Spina; Domenico Barbuti; Alberto Gaeta; Stefano Palmucci; Ernesto Soscia; Marco Grimaldi; Antonio Leone; Renzo Manara; Gabriele Polonara
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

9.  Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy.

Authors:  Abhijit Ricky Pal; Jean Mercer; Simon A Jones; Iain A Bruce; Brian W Bigger
Journal:  PLoS One       Date:  2018-09-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.